Advanced Research Institute

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Fatty liver disease (MASLD/MASH)1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Ellodi Pharmaceuticals, LP1 trial
• Ionis Pharmaceuticals, Inc.1 trial

Closed trials

• Completed

  24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)

  NCT05634746· Phase 3· Ellodi Pharmaceuticals, LP· Source

• Completed

  A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224

  NCT04932512· Phase 2· Ionis Pharmaceuticals, Inc.· Source